0001562180-24-002595.txt : 20240312 0001562180-24-002595.hdr.sgml : 20240312 20240312162036 ACCESSION NUMBER: 0001562180-24-002595 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240311 FILED AS OF DATE: 20240312 DATE AS OF CHANGE: 20240312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kiernan Matthew CENTRAL INDEX KEY: 0001993183 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39834 FILM NUMBER: 24742357 MAIL ADDRESS: STREET 1: 500 PRINCIPIO PARKWAY WEST STREET 2: SUITE 400 CITY: NORTH EAST STATE: MD ZIP: 21901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clene Inc. CENTRAL INDEX KEY: 0001822791 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 852828339 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 BUSINESS PHONE: 801-676-9695 MAIL ADDRESS: STREET 1: 6550 SOUTH MILLROCK DRIVE, SUITE G50 CITY: SALT LAKE CITY STATE: UT ZIP: 84121 FORMER COMPANY: FORMER CONFORMED NAME: Chelsea Worldwide Inc. DATE OF NAME CHANGE: 20200827 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-03-11 false 0001822791 Clene Inc. CLNN 0001993183 Kiernan Matthew 6550 SOUTH MILLROCK DRIVE SUITE G50 SALT LAKE CITY UT 84121 true false false false false Stock Options (Right to buy) 0.44 2024-03-11 4 A false 29481.00 0.00 A 2034-03-11 Common Stock 29481.00 29481.00 D This option was granted on March 11, 2024 as an option for 29,481 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.44 per share. The options vest immediately upon grant. /s/ Jerry Miraglia POA 2024-03-12